Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03332589
Brief Title: E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS)

First Submitted : October 30, 2017
First Submitted that Met QC Criteria : November 1, 2017
First Posted : November 6, 2017

Last Update Submitted that Met QC Criteria : April 29, 2020
Last Update Posted : May 1, 2020